HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Cusack Selected Research

Ribonucleoproteins

1/2020A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase.
10/2015An RNA Hybridization Assay for Screening Influenza A Virus Polymerase Inhibitors Using the Entire Ribonucleoprotein Complex.
9/2013Characterization of PA-N terminal domain of Influenza A polymerase reveals sequence specific RNA cleavage.
2/2012Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.
2/2010Towards an atomic resolution understanding of the influenza virus replication machinery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Cusack Research Topics

Disease

21Human Influenza (Influenza)
01/2022 - 04/2009
7Infections
01/2018 - 01/2007
2Stuttering (Stammering)
01/2020 - 12/2014
2Neoplasms (Cancer)
01/2020 - 09/2007
2Infertility (Sterility)
06/2014 - 10/2013
1Severe Fever with Thrombocytopenia Syndrome
01/2020
1Poisoning
10/2016
1Cryptosporidiosis
10/2016
1Toxoplasmosis
10/2016
1Tuberculosis (Tuberculoses)
10/2016
1Vesicular Stomatitis
02/2016
1Acquired Immunodeficiency Syndrome (AIDS)
11/2015
1Hemorrhage
08/2015
1Maxillofacial Injuries
08/2015
1Rabies (Hydrophobia)
01/2014
1Measles
01/2014
1Decompression Sickness (Bends)
04/2013
1Dehydration (Water Stress)
08/2011
1Keratoconjunctivitis
06/2009
1Onychomycosis (Tinea Unguium)
06/2007
1Wounds and Injuries (Trauma)
08/2006

Drug/Important Bio-Agent (IBA)

9Viral RNAIBA
01/2020 - 02/2010
7EndonucleasesIBA
01/2018 - 04/2009
6Pharmaceutical PreparationsIBA
01/2020 - 02/2010
6Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2010
6RNA (Ribonucleic Acid)IBA
01/2018 - 01/2014
5RibonucleoproteinsIBA
01/2020 - 02/2010
3Messenger RNA (mRNA)IBA
02/2016 - 09/2013
3DNA-Directed RNA Polymerases (RNA Polymerase)IBA
11/2015 - 01/2007
3MetalsIBA
01/2012 - 09/2010
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
10/2016 - 06/2007
2Antiviral Agents (Antivirals)IBA
10/2015 - 01/2012
2Amino AcidsFDA Link
02/2012 - 09/2010
1RNA Polymerase II (RNA Polymerase B)IBA
01/2022
1UridineIBA
01/2020
1NucleosidesIBA
01/2019
1ProdrugsIBA
01/2018
1baloxavirIBA
01/2018
1Interferon Type IIBA
01/2018
1AcidsIBA
01/2018
1Peptides (Polypeptides)IBA
01/2017
1Complementary RNA (cRNA)IBA
01/2017
1Transfer RNA (tRNA)IBA
10/2016
1Streptomycin (Streptomycin Sulfate)FDA Link
10/2016
1nitazoxanide (NTZ)FDA Link
10/2016
1Protein Synthesis InhibitorsIBA
10/2016
1Isoniazid (Ftivazide)FDA LinkGeneric
10/2016
1Piwi-Interacting RNAIBA
06/2014
1Adenosine Triphosphate (ATP)IBA
06/2014
1FLAG peptideIBA
01/2014
1LuciferasesIBA
01/2014
1Poly I-CIBA
01/2014
17-methylguanineIBA
11/2013
1Histone-Lysine N-MethyltransferaseIBA
10/2013
1NucleotidesIBA
04/2013
1Anti-Bacterial Agents (Antibiotics)IBA
03/2013
1Viral ProteinsIBA
02/2012
1Biological ProductsIBA
08/2011
1IonsIBA
09/2010
1Nucleic AcidsIBA
09/2010
1Sialic AcidsIBA
06/2009
12,4-dioxo-4-phenylbutanoic acidIBA
04/2009
1tavaboroleIBA
06/2007
1EnzymesIBA
06/2007
1IceIBA
08/2006

Therapy/Procedure

3Therapeutics
10/2016 - 09/2007
1Airway Management
08/2015